2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
AssigneeSanofi-Aventis Deutschland GmbH
InventorsJoachim Brendel, Heinz Goegelein, Klaus Wirth, Gert Kuerzel
Life of this patent
Estimating the term…
Abstract
The invention relates to 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3-yl)propyl]benzamide of the formula I and to its pharmaceutically acceptable salts, their preparation and use, in particular for the treatment and prophylaxis of atrial arrhythmias, for example atrial fibrillation or atrial flutters.
Claims8
1-7. (canceled)
A composition consisting of 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl]benzamide of the formula I
- or its physiologically tolerable salts.
The compound 1(R)-(6-Methoxypyridin-3-yl)propylamine.
A process for preparing the compound 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl]benzamide or its physiologically tolerable salts comprising the step of coupling a sulfonylaminobenzoic acid with 1(R)-(6-methoxypyridin-3-yl)propylamine.
Dependencies are inferred from the claim text.